Drug
Teplizumab Herold Regimen
Teplizumab Herold Regimen: highest development phase Phase 3, developed by MacroGenics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- MacroGenics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Teplizumab Herold Regimen NCT00920582 | Phase 3 | Type 1 Diabetes Mellitus |
Latest
No recent events.
Follow Teplizumab Herold Regimen on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.